BDF-3299 is a small molecule that has been investigated for its potential use in treating various conditions, including certain types of cancer. It is primarily known as a selective inhibitor of the protein MCL-1 (myeloid cell leukemia 1), which plays a role in regulating cell survival and apoptosis. By inhibiting MCL-1, BDF-3299 may help to induce cell death in cancer cells that are dependent on this protein for survival.
Articles by others on the same topic
There are currently no matching articles.